Youhaverights.com Legal Topics Podcast

Several studies have shown that the use of Depatkote (divalproex sodium) in pregnant women significantly increases the risk of birth defects, including: spinal bifida, cleft palate, hypospadia, heart deformities, facial dymorphism , limb reduction and skeletal defects. Depakote is marketed by Abbott Laboratories and is approved for the treatment of manic episodes associated with bipolar disorders and seizure disorders like epilepsy. If you have taken this drug while pregnant, contact Mark & Associates, P.C. today.